Home / MissionIR Articles

MissionIR Articles

  • Oakridge Global Energy Solutions, Inc. (OGES) Expanding Presence in International Energy Storage Markets following Corporate Restructuring

    Oakridge Global Energy Solutions is an integrated energy storage solutions company that uses state-of-the-art technology to design and develop advanced, high-quality cells, batteries and power systems. The company’s strategy is to deliver innovation while simultaneously…

  • XTL Biopharmaceuticals (XTLB) Presents at Rodman & Renshaw Conference

    XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) is a clinical-stage biopharmaceutical company focused on the acquisition, development, and commercialization of pharmaceutical products for the treatment of unmet clinical needs. XTL is focused on late stage clinical development…

  • Xtant Medical Holdings (BONE) Presents at Rodman & Renshaw Conference

    Xtant Medical Holdings, Inc. (NYSE: BONE) develops, manufactures and markets class-leading regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics…

  • Xinyuan Real Estate (XIN) Presents at Rodman & Renshaw Conference

    Xinyuan Real Estate Co., Ltd. (NYSE: XIN) is a real estate developer and property manager primarily in China and recently in other countries. In China, the company develops and manages large scale, high quality real…

  • Western Copper and Gold (WRN) Presents at Rodman & Renshaw Conference

    Western Copper and Gold (NYSE:WRN) is focused on advancing the Casino Project located in Yukon, Canada, one of the world’s largest copper, gold, silver and molybdenum deposits. Through its wholly owned subsidiary, Casino Mining Corporation,…

  • Vuzix® (VUZI) Presents at Rodman & Renshaw Conference

    Vuzix® Corp. (NASDAQ: VUZI) is a leading supplier of video eyewear and smart glasses products in the consumer, commercial and entertainment markets. The company’s products include personal display and wearable computing devices that offer users…

  • VolitionRX (VNRX) Presents at Rodman & Renshaw Conference

    Life sciences company VolitionRx (NYSE: VNRX) is developing diagnostic tests for cancer and other conditions. The tests are based on the science of Nucleosomics®, which is the practice of identifying and measuring nucleosomes in the…

  • Viveve Medical (VIVMF) Presents at Rodman & Renshaw Conference

    Viveve, Inc. (OTCQ: VIVMF), operating subsidiary of Viveve Medical, Inc., is a women’s health company committed to advancing new solutions to improve women’s overall well-being and quality of life. The company’s lead product, the globally…

  • Vista Gold (VGZ) Presents at Rodman & Renshaw Conference

    Vista Gold Corp. (NYSE:VGZ) principal asset is its flagship Mt Todd gold project in Northern Territory, Australia.  The company also holds approximately 4.9% of the outstanding common shares of Midas Gold Corp., non-core projects in…

  • Viggle (VGGL) Presents at Rodman & Renshaw Conference

    Viggle, Inc. (NASDAQ:VGGL) is an entertainment marketing and rewards platform whose app rewards its more than 9.0 million registered users for watching TV shows and discovering new music. Members can access the Viggle store via…

  • Vical (VICL) Presents at Rodman & Renshaw Conference

    Vical, Inc. (NASDAQ:VICL) applies its patented DNA delivery technologies and other therapeutic approaches to develop biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases. Headquartered in San Diego, California, Vical is…

  • Verastem (VSTM) Presents at Rodman & Renshaw Conference

    Verastem, Inc. (NASDAQ:VSTM) is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation. The company’s current product line includes: FAK, PI3K/mTOR and Wnt. Verastem’s proprietary research has…

  • VBI Vaccines (VBIV) Presents at Rodman & Renshaw Conference

    VBI Vaccines, Inc. (NASDAQ:VBIV) is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s lead eVLP asset is a prophylactic Cytomegalovirus (“CMV”) vaccine. The company has initiated…

  • Uranium Energy (UEC) Presents at Rodman & Renshaw Conference

    Uranium Energy Corp. (NYSE: UEC) is a U.S.-based uranium mining and exploration company with a  fully-licensed Hobson processing plant as the central point of all of its projects in South Texas, including the Palangana in-situ…

  • Ur-Energy (URG) Presents at Rodman & Renshaw Conference

    Ur-Energy, Inc. (NYSE: URG) is a uranium mining company operating the Lost Creek in-situ recovery uranium facility in south-central Wyoming. The Lost Creek processing facility has a two million pounds per year nameplate design capacity.…

  • UQM Technologies (UQM) Presents at Rodman & Renshaw Conference

    UQM Technologies Inc. (NYSE: UQM) develops and manufactures power-dense, high-efficiency electric motors, generators, power electronic controllers and fuel cell compressors for the commercial truck, bus, automotive, marine, military and industrial markets. A major emphasis for…

  • uniQure N.V (QURE) Presents at Rodman & Renshaw Conference

    uniQure N.V. (NASDAQ:QURE) participates in the field of gene therapy and has developed the first and currently the only gene therapy product to receive regulatory approval in the European Union. The company is developing a…

  • US Physical Therapy (USPH) Presents at Rodman & Renshaw Conference

    US Physical Therapy, Inc. (NYSE: USPH) operates 503 clinics in 42 states to provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries, and rehabilitation of injured…

  • TRACON Pharmaceuticals (TCON) Presents at Rodman & Renshaw Conference

    TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) develops targeted therapies for cancer, wet AMD and fibrotic diseases. The company’s current pipeline includes two clinical stage product candidates: TRC105, an anti-endoglin antibody that is being developed for the treatment…

  • Top Image Systems (TISA) Presents at Rodman & Renshaw Conference

    Top Image Systems™ Ltd. (NASDAQ:TISA) provides enterprise solutions for capturing and validating structured and unstructured content entering organizations from various sources and managing content-driven business processes. Whether originating from mobile, electronic, paper or other sources,…

  • Tonix Pharmaceuticals Holding (TNXP) Presents at Rodman & Renshaw Conference

    Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) is focused on the invention and development of novel pharmaceutical products for medical conditions that it believes have broad societal impact, and that are not well served by currently available…

  • Titan Pharmaceuticals (TTNP) Presents at Rodman & Renshaw Conference

    Titan Pharmaceuticals Inc. (OTCQB: TTNP) is a specialty pharmaceutical company developing proprietary therapeutics primarily for the treatment of serious medical disorders. The company’s lead product candidate, Probuphine®, is a novel and long-acting formulation of buprenorphine…

  • Threshold Pharmaceuticals (THLD) Presents at Rodman & Renshaw Conference

    Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) is a biotechnology company focused on the discovery and development of drugs targeting tumor hypoxia, the low oxygen condition found in the microenvironments of most solid tumors as well as the…

  • TG Therapeutics (TGTX) Presents at Rodman & Renshaw Conference

    TG Therapeutics, Inc. (NASDAQ:TGTX) is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Currently, the company is developing two therapies targeting hematological malignancies: TG-1101…

  • Tecogen (TGEN) Presents at Rodman & Renshaw Conference

    Tecogen Inc. (NASDAQ: TGEN) manufactures, installs and maintains high-efficiency, ultra-clean combined heat and power products – including natural gas engine-drive cogeneration, air conditioning systems and water heaters for residential, commercial and industrial use. For over…

  • TapImmune (TPIV) Presents at Rodman & Renshaw Conference

    TapImmune Inc. (OTCQB: TPIV) is an immunotherapy company specializing in the development of innovative technologies for the treatment of cancer and infectious diseases. The company’s peptide or nucleic acid-based immunotherapeutics comprise one or more naturally…

  • Stevia First (STVF) Presents at Rodman & Renshaw Conference

    Stevia First Corp. (OTCQB: STVF) is an agricultural biotechnology company enabling the production of dramatically healthier food and nutrition products. The company has developed and is commercializing a novel bioprocessing technique that has the potential…

  • Stemline Therapeutics (STML) Presents at Rodman & Renshaw Conference

    Stemline Therapeutics, Inc. (NASDAQ: STML) is a clinical stage biopharmaceutical company developing novel oncology therapeutics that primarily target cancer stem cells and tumor bulk. The company’s pipeline currently includes two clinical stage product candidates, SL-401…

  • StemCells (STEM) Presents at Rodman & Renshaw Conference

    StemCells, Inc. (NASDAQ: STEM) is currently engaged in the clinical development of its innovative HuCNS-SC® platform technology as a potential treatment for both neurological and retinal disorders. The company’s top-line data from its phase I/II…

  • Stellar Biotechnologies (SBOTF) Presents at Rodman & Renshaw Conference

    Stellar Biotechnologies, Inc. (OTCQB: SBOTF) is the leading manufacturer of sustainable keyhole limpet hemocyanin (KLH), an important immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets. Through a recently executed strategic collaboration, the company has…

  • SteadyMed (STDY) Presents at Rodman & Renshaw Conference

    SteadyMed Ltd. (NASDAQ: STDY) is a specialty pharmaceutical company focused on the development of drug products to treat orphan and high value diseases with unmet parental delivery needs. The company’s lead drug product candidate, Trevyent®,…

  • Spectrum Pharmaceuticals (SPPI) Presents at Rodman & Renshaw Conference

    Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) is a leading biotechnology company focused on acquiring, developing and commercializing drug products. The company currently markets five hematology/oncology drugs, and it expects an FDA decision on another hematology drug…

  • Sorrento Therapeutics (SRNE) Presents at Rodman & Renshaw Conference

    Sorrento Therapeutics, Inc. (NASDAQ: SRNE) is a clinical-stage biopharmaceutical company developing new treatments for cancer, as well as associated pain, inflammation and immune diseases. The company recently licensed multiple late-stage biosimilar and biobetter antibodies for…

  • Solar3D (SLTD) Presents at Rodman & Renshaw Conference

    Solar3D, Inc. (NASDAQ: SLTD) is a leading provider of solar power solutions focused on the design, installation and management of solar power systems for commercial, agricultural and residential customers. Through its wholly-owned subsidiaries, the company…

  • Social Reality (SCRI) Presents at Rodman & Renshaw Conference

    Social Reality, Inc. (OTCQB: SCRI) is an internet advertising company delivering a complete set of advertising and marketing tools and services powered by real-time automation. The company’s proprietary technology connects the social and digital spheres…

  • Smith Micro Software (SMSI) Presents at Rodman & Renshaw Conference

    Smith Micro Software, Inc. (NASDAQ: SMSI) is a provider of software designed to simplify and enhance the mobile experience. As the leader in wireless connectivity, the company’s applications ensure the best quality of experience for…

  • SITO Mobile (SITO) Presents at Rodman & Renshaw Conference

    SITO Mobile Ltd. (NASDAQ: SITO) provides a mobile engagement platform that enables brands to increase awareness, loyalty and sales. Through its location-based advertising services, the company helps clients drive foot traffic into stores and improve…

  • Signal Genetics (SGNL) Presents at Rodman & Renshaw Conference

    Signal Genetics, Inc. (NASDAQ: SGNL) is a commercial-stage molecular design company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company’s lead…

  • Second Sight Medical Products (EYES) Presents at Rodman & Renshaw Conference

    Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets innovative implantable visual prosthetics that enable blind individuals to achieve greater independence. The company’s lead product is the Argus® II Retinal Prosthesis System, which…

  • Safeguard Scientifics (SFE) Presents at Rodman & Renshaw Conference

    Safeguard Scientifics, Inc. (NYSE: SFE) has a distinguished track record of fostering innovation and building market leaders. For six decades, the company has been providing growth capital and operational support to entrepreneurs across an evolving…